Abstract: The invention provides methods of inhibiting cerebral amyloid angiopathy. The invention further provides methods of treating a disease state characterized by cerebral amyloid angiopathy in a subject with an A&bgr;40 inhibitor having the structure:
Q-[—SO3−X+]n or Q-[—OSO3−X+]n
wherein Q is a carrier group; X+ is a cationic group; and n is one.
Abstract: Therapeutic compounds and methods for modulating amyloid deposition in a subject, whatever its clinical setting, are described. Amyloid deposition is modulated by the administration to a subject of an effective amount of a therapeutic compound comprising a phosphonate group and a carboxylate group, a congener thereof, or a pharmaceutically acceptable salt or ester thereof. In preferred embodiments, an interaction between an amyloidogenic protein and a basement membrane constituent is modulated.
Type:
Grant
Filed:
May 17, 2001
Date of Patent:
August 27, 2002
Assignee:
Queen's University at Kingston
Inventors:
Walter A. Szarek, Xianqi Kong, Gregory R. J. Thatcher, Boris Gorine